REPLIGEN CORP Selling, General and Administrative Expense
REPLIGEN CORP (RGEN) reported Selling, General and Administrative Expense of $76.62 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-07-29
- REPLIGEN CORP selling, general and administrative expense for the quarter ending 2026-06-30 was $76.62M, a 8.06% increase year-over-year.
- REPLIGEN CORP selling, general and administrative expense for the quarter ending 2026-03-31 was $76.54M, a 8.25% increase year-over-year.
- REPLIGEN CORP selling, general and administrative expense for the quarter ending 2025-12-31 was $74.36M, a 22.97% increase year-over-year.
- REPLIGEN CORP selling, general and administrative expense for the quarter ending 2025-09-30 was $73.66M, a 2.58% decline year-over-year.
- REPLIGEN CORP selling, general and administrative expense for fiscal 2025 was $290.51M, a 10.30% increase from fiscal 2024.
- REPLIGEN CORP selling, general and administrative expense for fiscal 2024 was $263.37M, a 20.49% increase from fiscal 2023.
- REPLIGEN CORP selling, general and administrative expense for fiscal 2023 was $218.58M, a 1.28% increase from fiscal 2022.
- REPLIGEN CORP selling, general and administrative expense for fiscal 2022 was $215.83M, a 17.38% increase from fiscal 2021.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 3 month as first filed | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 6 month as first filed | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 9 month as first filed | Selling, General and Administrative Expense 12 month | Selling, General and Administrative Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $76.62M 10-Q · filed 2026-07-29 | $153.15M 10-Q · filed 2026-07-29 | $227.52M derived: sum of 3 quarters · filed 2026-07-29 | $301.18M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2026-03-31 | $76.54M 10-Q · filed 2026-05-06 | $150.90M derived: sum of 2 quarters · filed 2026-05-06 | $224.56M derived: sum of 3 quarters · filed 2026-05-06 | $295.47M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2025-12-31 | $74.36M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $148.03M derived: sum of 2 quarters · filed 2026-02-26 | $218.93M derived: sum of 3 quarters · filed 2026-07-29 | $290.51M 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | $73.66M 10-Q · filed 2025-11-04 | $144.57M derived: sum of 2 quarters · filed 2026-07-29 | $216.15M 10-Q · filed 2025-11-04 | $275.75M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2025-06-30 | $70.91M 10-Q · filed 2026-07-29 | $71.23M 10-Q · filed 2025-08-07 | $141.61M 10-Q · filed 2026-07-29 | $142.48M 10-Q · filed 2025-08-07 | $202.09M derived: sum of 3 quarters · filed 2026-07-29 | $277.70M derived: sum of 4 quarters · filed 2026-07-29 | ||
| 2025-03-31 | $70.71M 10-Q · filed 2026-05-06 | $71.25M 10-Q · filed 2025-04-29 | $131.18M derived: sum of 2 quarters · filed 2026-05-06 | $206.79M derived: sum of 3 quarters · filed 2026-05-06 | $272.27M derived: sum of 4 quarters · filed 2026-05-06 | |||
| 2024-12-31 | $60.47M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $136.08M derived: sum of 2 quarters · filed 2026-02-26 | $201.56M derived: sum of 3 quarters · filed 2026-02-26 | $263.37M 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | $75.61M 10-Q · filed 2025-11-04 | $141.09M derived: sum of 2 quarters · filed 2025-11-04 | $202.89M 10-Q · filed 2025-11-04 | $260.52M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-06-30 | $65.48M 10-Q · filed 2025-08-07 | $64.70M 10-Q · filed 2024-07-30 | $127.28M 10-Q · filed 2025-08-07 | $126.38M 10-Q · filed 2024-07-30 | $184.91M derived: sum of 3 quarters · filed 2026-02-26 | $240.50M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-03-31 | $61.80M 10-Q · filed 2025-04-29 | $61.69M 10-Q · filed 2024-05-01 | $119.43M derived: sum of 2 quarters · filed 2026-02-26 | $175.01M derived: sum of 3 quarters · filed 2026-02-26 | $224.10M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2023-12-31 | $57.63M derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-02-26 | $113.21M derived: sum of 2 quarters · filed 2026-02-26 | $162.30M derived: sum of 3 quarters · filed 2026-02-26 | $218.58M 10-K · filed 2026-02-26 | $218.11M 10-K · filed 2024-02-22 | |||
| 2023-09-30 | $55.58M 10-Q/A · filed 2024-11-18 | $55.47M 10-Q · filed 2023-10-31 | $104.67M derived: sum of 2 quarters · filed 2024-11-18 | $160.95M 10-Q/A · filed 2024-11-18 | $160.60M 10-Q · filed 2023-10-31 | $214.19M derived: sum of 4 quarters · filed 2025-03-14 | ||
| 2023-06-30 | $49.08M 10-Q/A · filed 2024-11-18 | $48.97M 10-Q · filed 2023-08-02 | $105.37M 10-Q/A · filed 2024-11-18 | $105.14M 10-Q · filed 2023-08-02 | $158.61M derived: sum of 3 quarters · filed 2025-03-14 | $212.25M derived: sum of 4 quarters · filed 2025-03-14 | ||
| 2023-03-31 | $56.29M 10-Q/A · filed 2024-11-18 | $56.17M 10-Q · filed 2023-05-02 | $109.53M derived: sum of 2 quarters · filed 2025-03-14 | $163.17M derived: sum of 3 quarters · filed 2025-03-14 | $217.82M derived: sum of 4 quarters · filed 2025-03-14 | |||
| 2022-12-31 | $53.24M derived: 10-K 12 month − 10-Q/A 9 month · filed 2025-03-14 | $106.88M derived: sum of 2 quarters · filed 2025-03-14 | $161.53M derived: sum of 3 quarters · filed 2025-03-14 | $215.83M 10-K · filed 2025-03-14 | ||||
| 2022-09-30 | $53.64M 10-Q/A · filed 2024-11-18 | $108.29M derived: sum of 2 quarters · filed 2024-11-18 | $162.59M 10-Q/A · filed 2024-11-18 | $214.65M derived: sum of 4 quarters · filed 2024-11-18 | ||||
| 2022-06-30 | $54.65M 10-Q/A · filed 2024-11-18 | $108.95M 10-Q/A · filed 2024-11-18 | $161.01M derived: sum of 3 quarters · filed 2024-11-18 | $209.38M derived: sum of 4 quarters · filed 2024-11-18 | ||||
| 2022-03-31 | $54.30M 10-Q/A · filed 2024-11-18 | $106.36M derived: sum of 2 quarters · filed 2024-11-18 | $154.73M derived: sum of 3 quarters · filed 2024-11-18 | $199.07M derived: sum of 4 quarters · filed 2024-11-18 | ||||
| 2021-12-31 | $52.06M derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-11-18 | $100.43M derived: sum of 2 quarters · filed 2024-11-18 | $144.77M derived: sum of 3 quarters · filed 2024-11-18 | $183.87M 10-K/A · filed 2024-11-18 | ||||
| 2021-09-30 | $48.37M 10-Q · filed 2022-11-01 | $92.71M derived: sum of 2 quarters · filed 2022-11-01 | $131.81M 10-Q · filed 2022-11-01 | $168.15M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2021-06-30 | $44.34M 10-Q · filed 2022-08-02 | $83.44M 10-Q · filed 2022-08-02 | $119.78M derived: sum of 3 quarters · filed 2023-02-22 | $148.83M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2021-03-31 | $39.09M 10-Q · filed 2022-04-27 | $75.44M derived: sum of 2 quarters · filed 2023-02-22 | $104.49M derived: sum of 3 quarters · filed 2023-02-22 | $131.22M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2020-12-31 | $36.34M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $65.39M derived: sum of 2 quarters · filed 2023-02-22 | $92.12M derived: sum of 3 quarters · filed 2023-02-22 | $119.62M 10-K · filed 2023-02-22 | ||||
| 2020-09-30 | $29.05M 10-Q · filed 2021-10-28 | $55.78M derived: sum of 2 quarters · filed 2021-10-28 | $83.28M 10-Q · filed 2021-10-28 | $111.56M derived: sum of 4 quarters · filed 2022-02-17 | ||||
| 2020-06-30 | $26.73M 10-Q · filed 2021-07-27 | $54.23M 10-Q · filed 2021-07-27 | $82.51M derived: sum of 3 quarters · filed 2022-02-17 | $107.14M derived: sum of 4 quarters · filed 2022-02-17 | ||||
| 2020-03-31 | $27.50M 10-Q · filed 2021-05-04 | $55.79M derived: sum of 2 quarters · filed 2022-02-17 | $80.42M derived: sum of 3 quarters · filed 2022-02-17 | $104.11M derived: sum of 4 quarters · filed 2022-02-17 | ||||
| 2019-12-31 | $28.29M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17 | $52.92M derived: sum of 2 quarters · filed 2022-02-17 | $76.61M derived: sum of 3 quarters · filed 2022-02-17 | $95.61M 10-K · filed 2022-02-17 | ||||
| 2019-09-30 | $24.63M 10-Q · filed 2020-11-05 | $48.33M derived: sum of 2 quarters · filed 2020-11-05 | $67.33M 10-Q · filed 2020-11-05 | $84.67M derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2019-06-30 | $23.70M 10-Q · filed 2020-07-30 | $42.70M 10-Q · filed 2020-07-30 | $60.04M derived: sum of 3 quarters · filed 2021-02-24 | $75.90M derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2019-03-31 | $19.00M 10-Q · filed 2020-05-06 | $36.34M derived: sum of 2 quarters · filed 2021-02-24 | $52.20M derived: sum of 3 quarters · filed 2021-02-24 | $68.79M derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2018-12-31 | $17.34M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $33.20M derived: sum of 2 quarters · filed 2021-02-24 | $49.79M derived: sum of 3 quarters · filed 2021-02-24 | $65.69M 10-K · filed 2021-02-24 | ||||
| 2018-09-30 | $15.86M 10-Q · filed 2019-10-31 | $32.45M derived: sum of 2 quarters · filed 2019-10-31 | $48.35M 10-Q · filed 2019-10-31 | $64.49M derived: sum of 4 quarters · filed 2019-10-31 | ||||
| 2018-06-30 | $16.59M 10-Q · filed 2019-08-01 | $32.49M 10-Q · filed 2019-08-01 | $48.63M derived: sum of 3 quarters · filed 2019-08-01 | $63.63M derived: sum of 4 quarters · filed 2019-08-01 | ||||
| 2018-03-31 | $15.90M 10-Q · filed 2019-05-09 | $32.04M derived: sum of 2 quarters · filed 2019-05-09 | $47.04M derived: sum of 3 quarters · filed 2019-05-09 | $58.23M derived: sum of 4 quarters · filed 2019-05-09 | ||||
| 2017-12-31 | $16.14M 10-K · filed 2018-02-22 | $31.14M derived: sum of 2 quarters · filed 2018-11-01 | $42.33M derived: sum of 3 quarters · filed 2018-11-01 | $51.51M 10-K · filed 2020-02-26 | ||||
| 2017-09-30 | $15.00M 10-Q · filed 2018-11-01 | $26.18M derived: sum of 2 quarters · filed 2018-11-01 | $35.37M 10-Q · filed 2018-11-01 | $43.93M derived: sum of 4 quarters · filed 2018-11-01 | ||||
| 2017-06-30 | $11.19M 10-Q · filed 2018-08-02 | $20.37M 10-Q · filed 2018-08-02 | $28.93M derived: sum of 3 quarters · filed 2018-08-02 | $36.06M derived: sum of 4 quarters · filed 2018-08-02 | ||||
| 2017-03-31 | $9.18M 10-Q · filed 2018-05-08 | $17.75M derived: sum of 2 quarters · filed 2018-05-08 | $24.88M derived: sum of 3 quarters · filed 2018-05-08 | $33.02M derived: sum of 4 quarters · filed 2018-05-08 | ||||
| 2016-12-31 | $8.57M 10-K · filed 2018-02-22 | $15.70M derived: sum of 2 quarters · filed 2018-02-22 | $23.84M derived: sum of 3 quarters · filed 2018-02-22 | $30.85M 10-K · filed 2019-03-01 | ||||
| 2016-09-30 | $7.13M 10-K · filed 2018-02-22 | $15.27M derived: sum of 2 quarters · filed 2018-02-22 | $22.29M 10-Q · filed 2017-11-09 | $28.76M derived: sum of 4 quarters · filed 2018-02-22 | ||||
| 2016-06-30 | $8.14M 10-Q · filed 2017-08-03 | $15.16M 10-Q · filed 2017-08-03 | $21.63M derived: sum of 3 quarters · filed 2018-02-22 | $27.59M derived: sum of 4 quarters · filed 2018-02-22 | ||||
| 2016-03-31 | $7.02M 10-K · filed 2018-02-22 | $13.49M derived: sum of 2 quarters · filed 2018-02-22 | $19.45M derived: sum of 3 quarters · filed 2018-02-22 | $25.69M derived: sum of 4 quarters · filed 2018-02-22 | ||||
| 2015-12-31 | $6.47M 10-K · filed 2017-02-23 | $12.43M derived: sum of 2 quarters · filed 2017-02-23 | $18.67M derived: sum of 3 quarters · filed 2017-02-23 | $24.70M 10-K · filed 2018-02-22 | ||||
| 2015-09-30 | $5.96M 10-K · filed 2017-02-23 | $12.20M derived: sum of 2 quarters · filed 2017-02-23 | $18.23M 10-Q · filed 2016-11-03 | $23.20M derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2015-06-30 | $6.24M 10-K · filed 2017-02-23 | $6.24M 10-Q · filed 2015-08-06 | $12.27M 10-Q · filed 2016-08-04 | $12.27M 10-Q · filed 2015-08-06 | $17.24M derived: sum of 3 quarters · filed 2017-02-23 | $21.71M derived: sum of 4 quarters · filed 2017-02-23 | ||
| 2015-03-31 | $6.02M 10-K · filed 2017-02-23 | $6.02M 10-Q · filed 2015-05-08 | $11.00M derived: sum of 2 quarters · filed 2017-02-23 | $15.47M derived: sum of 3 quarters · filed 2017-02-23 | $19.80M derived: sum of 4 quarters · filed 2017-02-23 | |||
| 2014-12-31 | $4.97M 10-K · filed 2016-02-25 | $9.45M derived: sum of 2 quarters · filed 2016-02-25 | $13.77M derived: sum of 3 quarters · filed 2016-02-25 | $17.15M 10-K · filed 2017-02-23 | $17.15M 10-K · filed 2015-03-17 | |||
| 2014-09-30 | $4.47M 10-K · filed 2016-02-25 | $4.47M 10-Q · filed 2014-11-07 | $8.80M derived: sum of 2 quarters · filed 2016-02-25 | $12.18M 10-Q · filed 2015-11-05 | $12.18M 10-Q · filed 2014-11-07 | $15.55M derived: sum of 4 quarters · filed 2016-02-25 | ||
| 2014-06-30 | $4.33M 10-K · filed 2016-02-25 | $4.33M 10-Q · filed 2014-08-11 | $7.71M 10-Q · filed 2015-08-06 | $11.08M derived: sum of 3 quarters · filed 2016-02-25 | $13.98M derived: sum of 4 quarters · filed 2016-02-25 | |||
| 2014-03-31 | $3.38M 10-K · filed 2016-02-25 | $3.38M 10-Q · filed 2014-05-09 | $6.75M derived: sum of 2 quarters · filed 2016-02-25 | $9.65M derived: sum of 3 quarters · filed 2016-02-25 | $12.78M derived: sum of 4 quarters · filed 2016-02-25 | |||
| 2013-12-31 | $3.37M 10-K · filed 2015-03-17 | $6.27M derived: sum of 2 quarters · filed 2015-03-17 | $9.39M derived: sum of 3 quarters · filed 2015-03-17 | $12.70M 10-K · filed 2016-02-25 | $12.70M 10-K · filed 2014-03-14 | |||
| 2013-09-30 | $2.90M 10-K · filed 2015-03-17 | $2.90M 10-Q · filed 2013-11-08 | $6.03M derived: sum of 2 quarters · filed 2015-03-17 | $9.33M 10-Q · filed 2014-11-07 | $12.59M derived: sum of 4 quarters · filed 2015-03-17 | |||
| 2013-06-30 | $3.12M 10-K · filed 2015-03-17 | $3.12M 10-Q · filed 2013-08-07 | $6.43M 10-Q · filed 2014-08-11 | $9.69M derived: sum of 3 quarters · filed 2015-03-17 | $12.81M derived: sum of 4 quarters · filed 2015-03-17 | |||
| 2013-03-31 | $3.31M 10-K · filed 2015-03-17 | $3.31M 10-Q · filed 2013-05-07 | $6.56M derived: sum of 2 quarters · filed 2015-03-17 | $9.69M derived: sum of 3 quarters · filed 2015-03-17 | $13.11M derived: sum of 4 quarters · filed 2015-03-17 | |||
| 2012-12-31 | $3.25M 10-K · filed 2014-03-14 | $6.38M derived: sum of 2 quarters · filed 2014-03-14 | $9.80M derived: sum of 3 quarters · filed 2014-03-14 | $13.23M 10-K · filed 2015-03-17 | ||||
| 2012-09-30 | $3.13M 10-K · filed 2014-03-14 | $3.13M 10-Q · filed 2012-11-08 | $6.54M derived: sum of 2 quarters · filed 2014-03-14 | $9.97M 10-Q · filed 2013-11-08 | $14.24M derived: sum of 4 quarters · filed 2014-03-14 | |||
| 2012-06-30 | $3.42M 10-K · filed 2014-03-14 | $3.42M 10-Q · filed 2012-08-09 | $6.85M 10-Q · filed 2013-08-07 | $11.11M derived: sum of 3 quarters · filed 2014-03-14 | $13.61M derived: sum of 4 quarters · filed 2014-03-14 | |||
| 2012-03-31 | $3.43M 10-K · filed 2014-03-14 | $3.67M 10-Q · filed 2012-05-10 | $7.70M derived: sum of 2 quarters · filed 2014-03-14 | $10.19M derived: sum of 3 quarters · filed 2014-03-14 | $12.48M derived: sum of 4 quarters · filed 2014-03-14 | |||
| 2011-12-31 | $4.27M 10-K · filed 2013-03-15 | $6.76M derived: sum of 2 quarters · filed 2013-03-15 | $9.05M 10-K · filed 2014-03-14 | $11.49M derived: sum of 4 quarters · filed 2013-03-15 | ||||
| 2011-09-30 | $2.49M 10-K · filed 2013-03-15 | $2.49M 10-Q · filed 2011-11-09 | $4.78M 10-Q · filed 2011-11-09 | $7.22M 10-Q · filed 2012-11-08 | $9.20M derived: sum of 4 quarters · filed 2014-03-14 | |||
| 2011-06-30 | $2.29M 10-K · filed 2013-03-15 | $2.29M 10-Q · filed 2011-08-05 | $4.73M 10-Q · filed 2012-08-09 | $6.71M derived: sum of 3 quarters · filed 2014-03-14 | $8.52M derived: sum of 4 quarters · filed 2014-03-14 | |||
| 2011-03-31 | $2.44M 10-K · filed 2013-03-15 | $2.44M 10-Q · filed 2012-05-10 | $4.42M derived: sum of 2 quarters · filed 2014-03-14 | $6.23M derived: sum of 3 quarters · filed 2014-03-14 | $8.02M 10-K · filed 2013-03-15 | |||
| 2010-12-31 | $1.98M derived: 10-K 9 month − 10-Q 6 month · filed 2014-03-14 | $3.79M derived: sum of 2 quarters · filed 2014-03-14 | $5.58M 10-K · filed 2014-03-14 | |||||
| 2010-09-30 | $1.81M 10-Q · filed 2011-11-09 | $3.60M 10-Q · filed 2011-11-09 | ||||||
| 2010-06-30 | $1.79M 10-Q · filed 2011-08-05 | |||||||
| 2010-03-31 | $7.07M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |